HIV Pre-Exposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men Only and Men Who Have Sex with Both Men and Women

Hess KL , Hu X , Lansky A , Mermin J , Hall HI . Lifetime risk of a diagnosis of HIV infection in the United States. Ann Epidemiol, 2017; 27:238–243.

Friedman MR , Wei C , Klem ML , Silvestre AJ , Markovic N , Stall R . HIV infection and sexual risk among men who have sex with men and women (MSMW): A systematic review and meta-analysis. PLoS One, 2014; 9:e87139.

Feinstein BA , Dyar C . Bisexuality, minority stress, and health. Curr Sex Health Rep, 2017; 9:42–49.

Friedman MR , Dodge B , Schick V , et al. From bias to bisexual health disparities: Attitudes toward bisexual men and women in the United States. LGBT Health, 2014; 1:309–318.

Friedman MR , Bukowski L , Eaton LA , et al. Psychosocial health disparities among Black bisexual men in the U.S.: Effects of sexuality nondisclosure and gay community support. Arch Sex Behav, 2019; 48:213–224.

Gaines MT , Hubbard McCree D , Gaul Z , Henny KD , Hickson DA , Sutton MY . Comparison of selected sociodemographic characteristics and sexual risk behaviors of black/African American men who have sex with men only and men who have sex with men and women, southeastern United States, 2013–2016. J Racial Ethn Health Disparities, 2020; 7:84–89.

Friedman MR , Sang JM , Bukowski LA , et al. Prevalence and correlates of PrEP awareness and use among Black men who have sex with men and women (MSMW) in the United States. AIDS Behav, 2019; 23:2694–2705.

Hammack PL , Meyer IH , Krueger EA , Lightfoot M , Frost DM . HIV testing and pre-exposure prophylaxis (PrEP) use, familiarity, and attitudes among gay and bisexual men in the United States: A national probability sample of three birth cohorts. PLoS One, 2018; 13:e0202806.

Powell VE , Gibas KM , DuBow J , Krakower DS . Update on HIV preexposure prophylaxis: Effectiveness, drug resistance, and risk compensation. Curr Infect Dis Rep, 2019; 21:28.

Spinner C , Brunetta J , Shalit P , et al. DISCOVER study for HIV pre-exposure prophylaxis (PrEP): F/TAF has a more rapid onset and longer sustained duration of HIV protection compared with F/TDF. In: Oral abstracts of the 10th IAS Conference on HIV Science, 21–24 July 2019, Mexico City, Mexico. Journal of the International AIDS Society, 2019.

Smith DK , Van H and el M , Grey J . Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Ann Epidemiol, 2018; 28:850–857.e9.

Harris NS , Satcher Johnson A , Huang Y-LA , et al. Vital Signs: Status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis—United States, 2013–2018. MMWR Morb Mortal Wkly Rep, 2019; 68:1117–1123.